当前位置：首页 > 文献互助 > 互助详情

期刊论文《中国抑郁障碍防治指南（2025版）》复制

MOMO 7个月前 137 已关闭

DOI:复制

文献链接:复制

其他信息:

上一篇：Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis

下一篇：Protective Effect of Composite Hydrogel Based on Hydroxypropyl Trimethylammonium Chloride Chitosan on Skin Photodamage

互助时间线

2025-12-05 09:38:32 [关闭求助]

楼主MOMO关闭了求助

2025-12-03 16:43:10 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 5分钟前

等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 21分钟前

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 33分钟前

Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 39分钟前

Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 40分钟前

Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 49分钟前

Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 55分钟前

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 57分钟前

Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前

Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前

Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前